150018-99-8 Usage
General Description
1-Benzyl-3-hydroxypiperidine-3-carbonitrile, also known as BHC, is a chemical compound that is commonly used in the synthesis of pharmaceuticals and agrochemical products. It is a piperidine derivative with a benzyl group and a hydroxyl group attached to the piperidine ring, as well as a carbonitrile functional group. BHC is primarily used as an intermediate in the production of various pharmaceuticals, including antihypertensive and anti-cancer drugs. It is also used in the synthesis of insecticides and bactericides. Due to its versatile chemical structure, BHC has a wide range of applications in the pharmaceutical and agricultural industries.
Check Digit Verification of cas no
The CAS Registry Mumber 150018-99-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,0,0,1 and 8 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 150018-99:
(8*1)+(7*5)+(6*0)+(5*0)+(4*1)+(3*8)+(2*9)+(1*9)=98
98 % 10 = 8
So 150018-99-8 is a valid CAS Registry Number.
InChI:InChI=1/C13H16N2O/c14-10-13(16)7-4-8-15(11-13)9-12-5-2-1-3-6-12/h1-3,5-6,16H,4,7-9,11H2
150018-99-8Relevant articles and documents
PHARMACOLOGICALLY ACTIVE ARYL-SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES
-
Page/Page column 28, (2018/10/19)
The present invention relates to new pyrazolo[1,5-a]pyrimidine derivatives of formula (I) or pharmaceutically acceptable salts, biologically active metabolites, pro-drugs, racemates, enantiomers, diastereomers, solvates and hydrates thereof that serve as GABAB receptor positive allosteric modulators. The invention also relates to the process for producing such compounds. The invention further relates to pharmaceutical compositions comprising such compounds optionally in combination with two or more different therapeutic agents and the use of such compounds in methods for treating diseases and conditions mediated and modulated by the GABAB receptor positive allosteric mechanism. The invention also provides a method for manufacture of medicaments useful in the treatment of such disorders.
